My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Chronic myelogenous leukemia: biology and therapy.

    Faderl S, Talpaz M, Estrov Z, Kantarjian HM.

    Ann Intern Med. 1999 Aug 3;131(3):207-19. Review.PMID: 10428738 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Targeted chronic myeloid leukemia therapy: seeking a cure.

    Fausel C.

    J Manag Care Pharm. 2007 Oct;13(8 Suppl A):8-12. Review.PMID: 17970609 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Chronic myelogenous leukemia.

    Enright H, McGlave PB.

    Curr Opin Hematol. 1996 Jul;3(4):303-9. Review.PMID: 9372092 [PubMed - indexed for MEDLINE]Related articles

    4.

    Chronic myelogenous leukemia.

    Enright H, McGlave PB.

    Curr Opin Hematol. 1995 Jul;2(4):293-9. Review. Erratum in: Curr Opin Hematol 1995 Nov;2(6):499. PMID: 9372010 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.

    Steinberg M.

    Clin Ther. 2007 Nov;29(11):2289-308. Review.PMID: 18158072 [PubMed - indexed for MEDLINE]Related articles

    6.

    Chronic myelogenous leukemia: update on biology and treatment.

    Faderl S, Kantarjian HM, Talpaz M.

    Oncology (Williston Park). 1999 Feb;13(2):169-80; discussion 181, 184. Review.PMID: 10079468 [PubMed - indexed for MEDLINE]Related articles

    7.

    Chronic myelogenous leukemia in chronic phase.

    Kurzrock R, Kantarjian H, Talpaz M.

    Curr Treat Options Oncol. 2001 Jun;2(3):245-52. Review.PMID: 12057124 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia]

    Sacha T, Hawrylecka D, Skotnicki AB.

    Przegl Lek. 1999;56 Suppl 1:62-6. Review. Polish. PMID: 10494185 [PubMed - indexed for MEDLINE]Related articles

    9.

    Biology and treatment of chronic myelogenous leukemia.

    Enright H, McGlave PB.

    Oncology (Williston Park). 1997 Sep;11(9):1295-300; discussion 1302-10.PMID: 9306419 [PubMed - indexed for MEDLINE]Related articles

    10.

    Bone marrow transplantation for chronic myelogenous leukemia.

    Enright H, McGlave P.

    Curr Opin Oncol. 1998 Mar;10(2):100-7. Review.PMID: 9555530 [PubMed - indexed for MEDLINE]Related articles

    11.

    Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.

    Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD.

    Eur J Haematol. 2003 Apr;70(4):235-9.PMID: 12656747 [PubMed - indexed for MEDLINE]Related articles

    12.

    Chronic myelogenous leukemia: a review.

    Cortes JE, Talpaz M, Kantarjian H.

    Am J Med. 1996 May;100(5):555-70. Review.PMID: 8644769 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Molecular targeted treatment--new treatment strategy for patients with chronic myeloid leukemia]

    Usui N.

    Rinsho Byori. 2004 Feb;52(2):136-44. Review. Japanese. PMID: 15027317 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Bcr-Abl inhibition as molecular therapy approach in chronic myeloid leukemia]

    Buchdunger E.

    Med Klin (Munich). 2002 Jan 15;97 Suppl 1:2-6. German. PMID: 11831067 [PubMed - indexed for MEDLINE]Related articles

    15.

    In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells.

    Scappini B, Onida F, Kantarjian HM, Dong L, Verstovsek S, Keating MJ, Beran M.

    Cancer. 2002 May 15;94(10):2653-62.PMID: 12173333 [PubMed - indexed for MEDLINE]Related articles

    16.

    Current therapy of chronic myelogenous leukemia.

    Garcia-Manero G, Talpaz M, Kantarjian HM.

    Intern Med. 2002 Apr;41(4):254-64. Review.PMID: 11993784 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.

    Kantarjian H, O'Brien S, Cortes J, Giles F, Thomas D, Kornblau S, Shan J, Beth Rios M, Keating M, Freireich E, Talpaz M.

    Cancer. 2003 Jul 1;98(1):81-5.PMID: 12833459 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells.

    Topaly J, Zeller WJ, Fruehauf S.

    Leukemia. 2001 Mar;15(3):342-7.PMID: 11237055 [PubMed - indexed for MEDLINE]Related articles

    19.

    Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase.

    Kantarjian HM, Cortes J, O'Brien S, Giles FJ, Albitar M, Rios MB, Shan J, Faderl S, Garcia-Manero G, Thomas DA, Resta D, Talpaz M.

    Blood. 2002 May 15;99(10):3547-53.PMID: 11986206 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Interferon alpha in the treatment of chronic myelogenous leukemia.

    Robak T.

    Arch Immunol Ther Exp (Warsz). 1998;46(6):347-53. Review.PMID: 9883313 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity